The first dendritic cell-based therapeutic cancer vaccine is approved by the FDA

Scand J Immunol. 2010 Dec;72(6):554. doi: 10.1111/j.1365-3083.2010.02464.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Cancer Vaccines / therapeutic use*
  • Clinical Trials, Phase III as Topic
  • Dendritic Cells / immunology*
  • Drug Approval*
  • Humans
  • Neoplasms / therapy*
  • Treatment Outcome
  • United States
  • United States Food and Drug Administration

Substances

  • Cancer Vaccines